<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140215016582N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-01-24</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of bioactive glass toothpaste on improving the early stages of dental caries during fixed orthodontic treatment</public_title>
      <acronym></acronym>
      <scientific_title>Effect of toothpaste containing Bioactiveglass in remineralization of white spot lesion during fixed orthodontic treatment: A randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>38</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52294</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Based on the block quantification method, it is divided into control group and study group by the researcher. The method of confiscation is that four blocks are used. If there are two treatments A and B, there are six different blocks as AABB, BBAA, ABAB, BABA, ABBA and BAAB. Random numbers between zero and one are now generated and the blocks are randomly selected based on random numbers. Thus, for numbers between 0 and 0.17, the first block, for numbers between 0.18 and 0.33, and the second block, for numbers between 0.34 and, Blinding description: In this study, patients are aware of the purpose of the study, which is to control white enamel lesions, but are blind to the product to be used in the study or to the group to which they belong. All tubes are covered by a blinding label. Assessments at all appointments are performed by an independent researcher who is blind to the groups. Statistical analysis is performed by a researcher who is blind to treatments.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Enamel white lesions.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Receiving toothpaste containing bioactive glass. In this group, the amount of tooth mineralization is first determined using a diagnostic laser made by the German company Kavo. Patients are then given toothpaste containing the bioactive glass (sensodyne, powered by Novamin) in a white tube without specifications and patients are instructed twice a day with a certain amount of toothpaste (about the size of a pea) for Brush their teeth for two minutes in 3 months. The amount of mineralization of the tooth is measured by the diagnostic device one and three months later. Intervention 2: Control group: Patients receiving fluoride toothpaste. In this group, the amount of tooth mineralization is first determined using a diagnostic laser made by the German company Kavo. Fluoride toothpaste (sensodyne, Rapid Relief) is then given to patients in a white tube without specifications and patients are instructed to take a certain amount of toothpaste (about the size of a pea) twice a day for two minutes. Brush their  teeth for 3 months. The amount of mineralization of the tooth is measured by the diagnostic device one and three months later.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individual data includes demographic characteristics and original outcome  information are shared

When:
Start the access period starts 6 months after printing  the results

To whom:
Researchers working in academic and scientific institutes and companies producing toothpaste

Conditions:
Unidentifiable information will not be provided due to the type of consent given to patients and the obligation of the investigator to comply with  ethical requirements.

Where to obtain:
Maryam Haidarpour: corresponding author, Maryamheydarpour @ gmail.com
Vahid Malabashi: First author, mollabashi@umsha.ac.ir

How to obtain:
After result publication through electronic E Mail of corresponding author and complete introduction and mention the goal from having the documentation, within a maximum one week related file is available to the applicant

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maryam Heydarpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Fahmide Ave</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>654178-38741</zip>
        <telephone>+98 81 3838 1059</telephone>
        <email>Maryamheydarpour97@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maryam Heydarpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Fahmide Ave</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>654178-38741</zip>
        <telephone>+98 81 3838 1059</telephone>
        <email>Maryamheydarpour97@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Fixed orthodontic applique on all teeth
Remain at least 3 months until the end of fixed orthodontic treatment
Having at least one white enamel lesion on the buccal surface of six anterior teeth and the first premolars in the maxilla or mandible</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>30 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Active dental caries
Active periodontal disease
Teeth with enamel defects
Teeth with internal and external discoloration such as fluorosis or tetracycline discoloration
Primary teeth
Facial-oral syndromes and cleft lip and palatal deformity
Patients under medical treatment or patients taking any type of medication</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K02</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Dental caries</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Receiving toothpaste containing bioactive glass. In this group, the amount of tooth mineralization is first determined using a diagnostic laser made by the German company Kavo. Patients are then given toothpaste containing the bioactive glass (sensodyne, powered by Novamin) in a white tube without specifications and patients are instructed twice a day with a certain amount of toothpaste (about the size of a pea) for Brush their teeth for two minutes in 3 months. The amount of mineralization of the tooth is measured by the diagnostic device one and three months later</i_keyword>
      <i_keyword>Control group: Patients receiving fluoride toothpaste. In this group, the amount of tooth mineralization is first determined using a diagnostic laser made by the German company Kavo. Fluoride toothpaste (sensodyne, Rapid Relief) is then given to patients in a white tube without specifications and patients are instructed to take a certain amount of toothpaste (about the size of a pea) twice a day for two minutes. Brush their  teeth for 3 months. The amount of mineralization of the tooth is measured by the diagnostic device one and three months later</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Change in white enamel lesions. Timepoint: At the beginning of the study and one month later and three months later. Method of measurement: Diagnodent laser device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-12-14</approval_date>
        <contact_name>Ethics committee of Hamadan University of Medical Science</contact_name>
        <contact_address>Shahid Fahmide Ave, Hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
